pαH-S-GSAS-B.1.351
(Plasmid
#171749)
-
PurposeMammalian expression of SARS-CoV-2 Spike protein S-GSAS-D614G-B.1.351 variant (South African)
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 171749 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepαH
- Backbone size w/o insert (bp) 4746
-
Vector typeMammalian Expression
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameSpike (S-GSAS-B.1.351 variant)
-
Alt nameSouth African SARS-CoV-2 spike variant
-
SpeciesSevere acute respiratory syndrome coronavirus 2
-
Insert Size (bp)3624
-
MutationEctodomain (AAs 1-1208); 682-685 (furin site = RRAR) replaced with GSAS; D614G; N501Y; K417N; E484K; L18F; D80A; D215G; R246I; A701V
-
Entrez GeneS (a.k.a. GU280_gp02, spike glycoprotein)
-
Tag
/ Fusion Protein
- HRV3C cleavage site, 8X His tag, 2X Strep-Tag II (C terminal on backbone)
Cloning Information
- Cloning method Gibson Cloning
- 5′ sequencing primer n/a (Common Sequencing Primers)
Resource Information
-
Supplemental Documents
-
A portion of this plasmid was derived from a plasmid made byJason McLellan
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
Please visit https://www.biorxiv.org/content/10.1101/2021.03.11.435037v2 for bioRxiv preprint.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pαH-S-GSAS-B.1.351 was a gift from Priyamvada Acharya (Addgene plasmid # 171749 ; http://n2t.net/addgene:171749 ; RRID:Addgene_171749) -
For your References section:
Effect of natural mutations of SARS-CoV-2 on spike structure, conformation, and antigenicity. Gobeil SM, Janowska K, McDowell S, Mansouri K, Parks R, Stalls V, Kopp MF, Manne K, Li D, Wiehe K, Saunders KO, Edwards RJ, Korber B, Haynes BF, Henderson R, Acharya P. Science. 2021 Jun 24. pii: science.abi6226. doi: 10.1126/science.abi6226. 10.1126/science.abi6226 PubMed 34168071